294 related articles for article (PubMed ID: 31407506)
1. Fusion transcripts: Unexploited vulnerabilities in cancer?
Neckles C; Sundara Rajan S; Caplen NJ
Wiley Interdiscip Rev RNA; 2020 Jan; 11(1):e1562. PubMed ID: 31407506
[TBL] [Abstract][Full Text] [Related]
2. Chimeric RNAs generated by intergenic splicing in normal and cancer cells.
Jividen K; Li H
Genes Chromosomes Cancer; 2014 Dec; 53(12):963-71. PubMed ID: 25131334
[TBL] [Abstract][Full Text] [Related]
3. The landscape and therapeutic relevance of cancer-associated transcript fusions.
Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG
Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544
[TBL] [Abstract][Full Text] [Related]
4. Oncocers: ceRNA-mediated cross-talk by sponging miRNAs in oncogenic pathways.
Ergun S; Oztuzcu S
Tumour Biol; 2015 May; 36(5):3129-36. PubMed ID: 25809705
[TBL] [Abstract][Full Text] [Related]
5. Functional and regulatory impact of chimeric RNAs in human normal and cancer cells.
Mukherjee S; Mukherjee SB; Frenkel-Morgenstern M
Wiley Interdiscip Rev RNA; 2023; 14(5):e1777. PubMed ID: 36633099
[TBL] [Abstract][Full Text] [Related]
6. Chimeric RNAs in cancer.
Shi X; Singh S; Lin E; Li H
Adv Clin Chem; 2021; 100():1-35. PubMed ID: 33453863
[TBL] [Abstract][Full Text] [Related]
7. Fusion Genes and RNAs in Cancer Development.
Taniue K; Akimitsu N
Noncoding RNA; 2021 Feb; 7(1):. PubMed ID: 33557176
[TBL] [Abstract][Full Text] [Related]
8. InFusion: Advancing Discovery of Fusion Genes and Chimeric Transcripts from Deep RNA-Sequencing Data.
Okonechnikov K; Imai-Matsushima A; Paul L; Seitz A; Meyer TF; Garcia-Alcalde F
PLoS One; 2016; 11(12):e0167417. PubMed ID: 27907167
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in cancer fusion transcript detection.
Dorney R; Dhungel BP; Rasko JEJ; Hebbard L; Schmitz U
Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36527429
[TBL] [Abstract][Full Text] [Related]
10. Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.
Shkreta L; Bell B; Revil T; Venables JP; Prinos P; Elela SA; Chabot B
Cancer Treat Res; 2013; 158():41-94. PubMed ID: 24222354
[TBL] [Abstract][Full Text] [Related]
11. The landscape of chimeric RNAs in bladder urothelial carcinoma.
Zhu D; Singh S; Chen X; Zheng Z; Huang J; Lin T; Li H
Int J Biochem Cell Biol; 2019 May; 110():50-58. PubMed ID: 30818082
[TBL] [Abstract][Full Text] [Related]
12. Cryptic splice site activation during RNA processing of MLL/AF4 chimeric transcripts in infants with t(4;11) positive ALL.
Divoky V; Trka JM; Watzinger F; Lion T
Gene; 2000 Apr; 247(1-2):111-8. PubMed ID: 10773450
[TBL] [Abstract][Full Text] [Related]
13. Alternative splicing in cancers: From aberrant regulation to new therapeutics.
Song X; Zeng Z; Wei H; Wang Z
Semin Cell Dev Biol; 2018 Mar; 75():13-22. PubMed ID: 28919308
[TBL] [Abstract][Full Text] [Related]
14. Chimeric RNAs as potential biomarkers for tumor diagnosis.
Zhou J; Liao J; Zheng X; Shen H
BMB Rep; 2012 Mar; 45(3):133-40. PubMed ID: 22449698
[TBL] [Abstract][Full Text] [Related]
15. HNRNPH1-dependent splicing of a fusion oncogene reveals a targetable RNA G-quadruplex interaction.
Neckles C; Boer RE; Aboreden N; Cross AM; Walker RL; Kim BH; Kim S; Schneekloth JS; Caplen NJ
RNA; 2019 Dec; 25(12):1731-1750. PubMed ID: 31511320
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the investigation of fusion RNAs and their role in molecular pathology of cancer.
Xu SM; Cheng Y; Fisher H; Janitz M
Int J Biochem Cell Biol; 2024 Mar; 168():106529. PubMed ID: 38246262
[TBL] [Abstract][Full Text] [Related]
17. Chimeric RNAs and their implications in cancer.
Li Z; Qin F; Li H
Curr Opin Genet Dev; 2018 Feb; 48():36-43. PubMed ID: 29100211
[TBL] [Abstract][Full Text] [Related]
18. Fusion Transcripts of Adjacent Genes: New Insights into the World of Human Complex Transcripts in Cancer.
Barresi V; Cosentini I; Scuderi C; Napoli S; Di Bella V; Spampinato G; Condorelli DF
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31652751
[TBL] [Abstract][Full Text] [Related]
19. [Perspectives of RNA interference application in the therapy of diseases associated with defects in alternative RNA splicing].
Wysokiński D; Błasiak J
Postepy Hig Med Dosw (Online); 2012 Sep; 66():683-95. PubMed ID: 23001210
[TBL] [Abstract][Full Text] [Related]
20. Intergenically Spliced Chimeric RNAs in Cancer.
Jia Y; Xie Z; Li H
Trends Cancer; 2016 Sep; 2(9):475-484. PubMed ID: 28210711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
